Gray matter volume and microRNA levels in patients with attention-deficit/hyperactivity disorder

被引:18
|
作者
Wang, Liang-Jen [1 ,2 ]
Li, Sung-Chou [3 ]
Kuo, Ho-Chang [4 ,5 ]
Chou, Wen-Jiun [1 ]
Lee, Min-Jing [1 ]
Chou, Miao-Chun [1 ]
Tseng, Huai-Hsuan [6 ]
Hsu, Chia-Fen [7 ]
Lee, Sheng-Yu [8 ,9 ]
Lin, Wei-Che [10 ]
机构
[1] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Child & Adolescent Psychiat, Kaohsiung, Taiwan
[2] Chang Gung Univ, Dept Chinese Med, Taoyuan, Taiwan
[3] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Genom & Prote Core Lab,Dept Med Res, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Pediat, Kaohsiung, Taiwan
[5] Kaohsiung Chang Gung Mem Hosp, Kawasaki Dis Ctr, Kaohsiung, Taiwan
[6] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Psychiat, Coll Med, Tainan, Taiwan
[7] Chung Shan Med Univ Hosp, Dept Psychol, Clin Psychol Room, Taichung, Taiwan
[8] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan
[9] Kaohsiung Med Univ, Sch Med, Grad Inst Med, Dept Psychiat,Coll Med, Kaohsiung, Taiwan
[10] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, 123 Da Pei Rd, Kaohsiung, Taiwan
关键词
ADHD; Brain imaging; Epigenetic; miRNA; Cortex; DEFICIT-HYPERACTIVITY DISORDER; SUBSTANCE USE DISORDERS; BRAIN ACTIVATION; GENETIC-VARIANTS; ADHD; CHILDREN; ASSOCIATION; ADOLESCENTS; CORTEX; ABNORMALITIES;
D O I
10.1007/s00406-019-01032-x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder often characterized by gray matter (GM) volume reductions. MicroRNAs, which participate in regulating gene expression, potentially influence neurodevelopment. This study aimed to explore whether differential GM volume is associated with differential miRNA levels in ADHD patients. We recruited a total of 30 drug-naive patients with ADHD (mean age 10.6 years) and 25 healthy controls (mean age 10.6 years) that underwent a single session of 3.0-T whole brain structural MRI scanning. RNA samples from the participants' white blood cells were collected to identify the Delta Ct values of three miRNAs (miR-30e-5p, miR-126-5p, and miR-140-3p) using the real-time quantitative reverse transcription polymerase chain reaction. In comparison to the control group, ADHD patients demonstrated a significantly lower GM volume in the cingulate gyrus, left middle temporal gyrus, right middle occipital gyrus, left fusiform gyrus, and significantly higher Delta Ct values of miR-30e-5p, miR-126-5p, and miR-140-3p. In the ADHD group, the GM volume of cingulate gyrus and left fusiform gyrus was negatively correlated with the Delta Ct values of miR-30e-5p, miR-140-3p. The GM volume of left fusiform gyrus was negatively correlated to ADHD behavioral symptoms. Using structural equation modeling (SEM), we observed that the effect of miR-140-3p on hyperactivity/impulsivity symptoms was mediated by left fusiform gyrus. Our findings support that GM volume reduction and miRNA increases may be biomarkers for ADHD in children and adolescents. Expression levels of miRNAs may affect the development of brain structures and further participate in the pathophysiology of ADHD.
引用
收藏
页码:1037 / 1045
页数:9
相关论文
共 50 条
  • [1] Gray matter volume and microRNA levels in patients with attention-deficit/hyperactivity disorder
    Liang-Jen Wang
    Sung-Chou Li
    Ho-Chang Kuo
    Wen-Jiun Chou
    Min-Jing Lee
    Miao-Chun Chou
    Huai-Hsuan Tseng
    Chia-Fen Hsu
    Sheng-Yu Lee
    Wei-Che Lin
    [J]. European Archives of Psychiatry and Clinical Neuroscience, 2020, 270 : 1037 - 1045
  • [2] Attention-deficit hyperactivity disorder in childhood and adolescence is associated with reduced gray matter volume in the thalamus
    Tomoda, Akemi
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2013, 22 : S244 - S244
  • [3] Discrete Global but No Focal Gray Matter Volume Reductions in Unmedicated Adult Patients With Attention-Deficit/Hyperactivity Disorder
    Maier, Simon
    Perlov, Evgeniy
    Graf, Erika
    Dieter, Elena
    Sobanski, Esther
    Rump, Marthe
    Warnke, Andreas
    Ebert, Dieter
    Berger, Mathias
    Matthies, Swantje
    Philipsen, Alexandra
    van Elst, Ludger Tebartz
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 80 (12) : 905 - 915
  • [4] Integrated analysis of gray and white matter alterations in attention-deficit/hyperactivity disorder
    Francx, Winke
    Llera, Alberto
    Mennes, Maarten
    Zwiers, Marcel P.
    Faraone, Stephen V.
    Oosterlaan, Jaap
    Heslenfeld, Dirk
    Hoekstra, Pieter J.
    Hartman, Catharina A.
    Franke, Barbara
    Buitelaar, Jan K.
    Beckmann, Christian F.
    [J]. NEUROIMAGE-CLINICAL, 2016, 11 : 357 - 367
  • [6] Attention: Attention-deficit/hyperactivity disorder
    Shulman, Stanford T.
    [J]. PEDIATRIC ANNALS, 2008, 37 (01): : 5 - 6
  • [7] Families of patients with attention-deficit hyperactivity disorder
    Jerome, L
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1997, 42 (02): : 211 - 211
  • [8] Cortisol levels in children with Attention-Deficit/Hyperactivity Disorder
    Isaksson, Johan
    Nilsson, Kent W.
    Nyberg, Fred
    Hogmark, Asa
    Lindblad, Frank
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2012, 46 (11) : 1398 - 1405
  • [9] Malondialdehyde levels in adult attention-deficit hyperactivity disorder
    Bulut, Mahmut
    Selek, Salih
    Gergerlioglu, H. Serdar
    Savas, Haluk A.
    Yilmaz, H. Ramazan
    Yuce, Murat
    Ekici, Giyasettin
    [J]. JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 2007, 32 (06): : 435 - 438
  • [10] Attention-deficit hyperactivity disorder
    Posner, Jonathan
    Polanczyk, Guilherme V.
    Sonuga-Barke, Edmund
    [J]. LANCET, 2020, 395 (10222): : 450 - 462